Complete and Durable Response to Tamoxifen and Ovarian Ablation in the Treatment of Metastatic Breast Cancer.

In a 2012 report involving 20,000 women in 20 randomized trials, the Early Breast Cancer Trialists’ Collaborative Group reported that five years of tamoxifen versus no tamoxifen resulted in a highly significant one-third reduction in breast cancer mortality [ 5 ].

also in 132,142 other papers